AddedRisk Factors
If we are unable to certify the effectiveness of our internal controls, or if our internal controls have material weaknesses, we may not detect errors in a timely manner, our financial statements could be misstated, we could be subject to regulatory scrutiny and a loss of confidence by stakeholders, which could harm our business, financial condition and results of operations and adversely affect the market price of our securities. We may also face litigation as a result of the material weaknesses in our internal control over financial reporting. Any such litigation, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RemovedRisk Factors
If we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results accurately or prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation and adversely impact the trading price of our common stock.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
Effective internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any current internal control deficiencies may adversely affect our financial condition, results of operations and access to capital.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
Subsequent to the issuance of our Annual Report on Form 10-K for the year ended December 31, 2023, and our subsequent retention of BPM LLP to replace BF Borgers CPA PC as our independent registered public accounting firm, management became aware of various adjustments to be recorded to our consolidated financial statements. On September 11, 2024, we filed Amendment 1 to our Annual Report on Form 10-K for the year ended December 31, 2023, restating our financial statements for the years ended December 31, 2023 and 2022 to correct errors primarily related to purchase accounting for the QPhoton Merger, stock-based compensation, and financing costs. We also amended our financial statements for the nine months ended September 30, 2023, in line with the restatement of our annual financial statements. These corrections impacted net loss, goodwill, intangible assets, liabilities, and stockholders’ equity.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
These restatements were necessitated in part by deficiencies in our internal control over financial reporting, which management concluded was not effective as of September 30, 2024. Material weaknesses in our controls, including those related to the timely detection and correction of financial reporting errors, coupled with the replacement of our independent auditor, resulted in delayed filings of our Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, and June 30, 2024.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
As a result of the failure to timely file our Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 and June 30, 2024, we are currently ineligible to register the offer and sale of our securities using a newly filed registration statement on Form S-3. As of December 31, 2024, we have fully utilized the $100 million “shelf” registration statement on Form S-3 that the SEC declared effective on November 8, 2022.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
“Penny stock” rules may make buying or selling our common stock difficult, which may make our stock less liquid and make it harder for investors to buy and sell our securities.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
Trading in our common stock has from time to time been and may continue to be subject to the SEC’s “penny stock” rules. The SEC has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to certain exceptions. These rules require that any broker-dealer that recommends our common stock to persons other than prior customers and accredited investors must, prior to the sale, make a special written suitability determination for the purchaser and receive the purchaser’s written agreement to execute the transaction. Unless an exception is available, the regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock market and the risks associated with trading in the penny stock market. In addition, broker-dealers must disclose commissions payable to both the broker-dealer and the registered representative and current quotations for the securities they offer. The additional burdens imposed upon broker-dealers by these requirements may discourage broker-dealers from effecting transactions in our common stock, which could severely limit the liquidity of, and consequently adversely affect the market price for, our common stock.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RewordedRisk Factors
We incurred net losses each year since 2018 and we believe that we will expect to continue to incur operating and net losses each quarter until at least for the time foreseeable future and may never achieve or sustain profitability, even if we begin generating significant revenue from our products and services, which may never occur.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we expect to regain eligibility to use Form S-3 as of September 1, 2025, there There can be no guarantees that we will remain timely and current in our public reporting through such date. in the future.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our success also depends in part on the manufacturing of TFLN Optical Chips. Chips for which we may rely, at least in part, on third-party manufacturers and suppliers.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
To regain maintain eligibility to use Form S-3, we must be timely and current in our public reporting for a period of 12 months preceding our intended S-3 filing. reporting.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our success will depend upon business model depends on our ability to expand, expand and scale our operations, operations and to increase our sales and support capability.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
As a result of our limited operating history, our ability to accurately forecast our future results of operations is limited limited, inherently uncertain and subject to a number of uncertainties, numerous factors outside our control, including our ability to plan for and model future growth.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we are unable to generate significant revenues in future periods, we will not be able to achieve profitability, and even if we should achieve, achieve profitability, we may be unable to maintain profitability. it.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
We may be unable to achieve or sustain profitability or remain a going concern. continue operations as planned.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
As of December 31, 2024 2025 and 2023, 2024, our accumulated deficit was $200.5 $219.2 million and $131.9 $200.5 million, respectively.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our ability to utilize our federal net operating loss carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes, including potential changes in connection with the QPhoton Merger Merger, the acquisition of Luminar Semiconductor, Inc., or other transactions.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
Should we wish to register the offer and sale of our securities to the public prior to without the time we are eligible ability to use Form S-3, both our transaction costs and the amount of time required to complete the transaction could increase, making it more difficult to execute any such transaction successfully and potentially harming our financial condition.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedRisk Factors
As of March 18, 2025, February 27, 2026, our directors and executive officers collectively beneficially own approximately 20.1% 12.4% of the shares of our common stock including the beneficial ownership of Dr.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Our quantum computers are inherently complex and incorporate technology and components that may note not have been used for computing products and that may contain defects and errors, particularly when first introduced.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
A substantial minority Some of our outstanding shares of common stock are “restricted securities” within the meaning of Rule 144 under the Securities Act.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
On December 15, 2025, we entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Luminar Technologies, Inc., a Delaware corporation (the “Seller”) and Luminar, pursuant to which, subject to the terms and conditions set forth in the Stock Purchase Agreement, the Company agreed to acquire all of the issued and outstanding shares of common stock of Luminar from the Seller (the “Luminar Acquisition”) for a total purchase price of $110 million in cash (the “Purchase Price”). The Luminar Acquisition was completed on February 2, 2026. $11.0 million of the Purchase Price was placed with an escrow agent in connection with the signing of the Stock Purchase Agreement. The escrowed amount will remain with the escrow agent to cover certain limited indemnification obligations of the Seller pursuant to the Stock Purchase Agreement until February 2, 2027.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
The Seller, together with certain of its subsidiaries, is a debtor in a voluntary Chapter 11 case before the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”), which commenced on December 15, 2025. Luminar is not a debtor in such Chapter 11 case and is operating in the ordinary course of business. Upon Bankruptcy Court approval, the Company was designated as the “stalking horse” bidder in connection with a sale of Luminar under Section 363 of the Bankruptcy Code. The Luminar Acquisition was conducted through a Bankruptcy Court-supervised process pursuant to Bankruptcy Court-approved bidding procedures and was subject to the receipt of higher or better offers from competing bidders at an auction, approval of the sale by the Bankruptcy Court, and the satisfaction of certain conditions.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
Macroeconomic conditions, including inflation, interest rates and currency fluctuations, have directly and indirectly impacted, and could in the future materially impact, the Company’s results of operations and financial condition. Our business may be affected by disruptions or delays to the federal government budget. We are subject to a lengthy product commercialization timeline and a lengthy sales cycle. Beginning in the second quarter of 2025, new U.S. tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
Sales and marketing expenses during the year ended December 31, 2025 increased $1.6 million or 89% compared with 2024 primarily due to increases in the sales staff, higher tradeshow and travel-related costs and increased marketing program costs. During the year ended December 31, 2025 the sales and marketing team participated in 1or 2 conferences and trade shows per month, compared to 1 or 2 trade shows per quarter during 2024, including greater participation in international quantum technology events, resulting in higher travel expenses.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
General and administrative expenses during the year ended December 31, 2025 increased $14.3 million or 111% compared with 2024 primarily due to higher employee and advisor-related expenses relating to development and implementation of internal financial controls, expansion of accounting staff, increased recruiting fees and legal expenses related to multiple financings, mergers and acquisition activity, and ongoing litigation.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
Interest and other income, net, during the year ended December 31, 2025 increased $20,295 or 4,798% compared with 2024 primarily due to the Company maintaining higher cash balances in mutual funds, deposit and money market accounts, U.S. Treasuries and corporate bonds during as a result of the substantial amount of new funding the Company raised in 2025.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
Interest expense during the year ended December 31, 2025 decreased $2,431 or 97% compared with 2024 primarily due to a decrease of interest on financial liabilities as the related borrowings were paid off during 2024. Interest expense during the year ended December 31, 2025 is related to late payroll tax filings.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
AddedMD&A
We believe that our existing cash, cash equivalents and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months, although we may choose to take advantage of opportunistic capital raising or refinancing transactions at any time.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RemovedMD&A
You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K,
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedMD&A
General and administrative expenses in 2024 decreased $2.8 million or 27% compared with 2023 primarily due to lower employee- and advisor-related expenses, including stock-based compensation, payroll, bonus and travel expenses, as well as lower legal fees and consulting services driven by changes made within and by the Company’s management team, offset by increased audit fees driven by the Company retaining a new independent registered public accounting firm in May 2024and such firm’s re-audit of the Company’s consolidated financial statements for the years ended December 31, 2023 and 2022.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedMD&A
Net selling and marketing expenses in 2024 were largely unchanged as compared with 2023, with increases primarily due to higher stock-based compensation, offset by lower outsourced professional services costs, related marketing program costs, and lower trade show and travel-related costs in 2024.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedMD&A
Non-operating expense increased to $42.6 million for 2024 compared to $779 thousand for 2023, primarily as the result of a $40.5 million decrease in the change in fair value of the derivative liability for the QPhoton Warrants, as defined below, during 2024 compared to a $528 thousand increase in 2023.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RemovedMD&A
In addition, interest expense, net, which consists of interest on financial liabilities and amortization of debt issuance costs, increased $128 thousand or 43% in 2024 compared to 2023, which increase was primarily attributable to interest paid on the secured convertible promissory note in the original principal amount of $8.25 million that we issued to Streeterville Capital, LLC in August 2024 (the “Streeterville Convertible Note”), which we paid in full as of December 31, 2024. See Note 7, Financial Liabilities, in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information.
Read it in 10-K Mar 20, 2025 at sec.govopen_in_new
RewordedMD&A
Operating expenses of approximately $51.1 million during the year ended December 31, 2025 increased as compared to approximately $26.0 million in 2024 decreased as compared to approximately $26.4 million in 2023 primarily as a result of a decrease in higher research and development expenses, sales and marketing expenses and general and administrative expenses, partially offset by an increase in research and development expenses, as set forth in the below tables (in thousands, except percentages).
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Net cash used in investing activities for the years ended December 31, 2025 and 2024 and 2023 was $6.0 $788.3 million and $2.6 $6.0 million, respectively, and was attributable to our purchase of computer hardware, laboratory equipment and TFLN Optical Chips manufacturing equipment for our AZ Chips Facility, equipment, as well as computer hardware and laboratory equipment. the purchase of $1,197.9 million in available-for-sale-debt securities offset by $376.3 million in proceeds from sales of available-for-sale-debt securities.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
The loss on change in value of the warrant liability is entirely a non-cash charge comprised of mark-to-market adjustments for the QPhoton Warrants, as Warrants (as defined below in the accompanying notes to our consolidated financial statements appearing elsewhere in this report, which had no carrying value as of December 31, 2023. below).
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Interest and other income income, net 20,718 423 295 43 4,798 Interest expense, net expense (65) (2,496) (1,602) 56 (97 Change in fair value of warrant liabilities derivative liability 11,750 (40,532) 528 NM 129 Total non-operating income (expense) (expense), net 32,403 (42,605) (779) NM (176 Net loss $ (18,674) $ (68,542) $ (27,022) 154 (73
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31 % 2025 2024 2023 Change Interest and other income income, net $ 20,718 $ 423 $ 295 43% 4,798 Interest expense, net expense (65) (2,496) (1,602) 56% (97 Change in fair value of derivative and warrant liabilities liability 11,750 (40,532) 528 NM 129 Other income (expense) (expense), net $ 32,403 $ (42,605) $ (779) NM (176
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
The following discussion and analysis of the our financial condition and results of operations and financial condition for the years ended December 31, 2024 and 2023 should be read in conjunction with our consolidated financial statements and the related notes to those consolidated financial statements that are included elsewhere in this Annual Report. Report on Form 10-K.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
The increase for 2024 2025 was predominantly driven by primarily due to the increases in direct labor expenses on R&D services contracts and custom hardware contracts, an increase in production overhead, and increased other direct costs (primarily parts and materials) required to perform on the contracts during 2024 the 2025 compared to the prior year.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Actual Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. certain factors including, but not limited to, those discussed under Item 1A, “Risk Factors.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
We will require a significant amount of cash for continued investment in our Foundry Services offering, including but not limited to future-identified space for expansion of our AZ Chips Facility and any future-identified space for expansion, Facility, as well as the construction or acquisition of a high-volume chip manufacturing facility, as well as ongoing research and development for our non-linear quantum optical products and photonics chips.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Research and development 20,473 11,318 8,891 27 81 Sales and marketing 3,431 1,818 1,806 1 89 General and administrative 27,240 12,913 15,708 (18 111 Total operating expenses 51,144 26,049 26,405 (1 96 Loss from operations (51,077) (25,937) (26,243) (1 97 Non-operating income and (expense):
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Our This discussion includes contains forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. uncertainties.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new
RewordedMD&A
Future mark-to-market adjustments may result in continued losses if the Company’s stock price of the Company’s common stock increases above the Company’s closing bid price of $16.55 $10.26 per share at on December 31, 2024; 2025; such adjustments may alternatively result in gains if the closing bid share price of the Company’s common stock decreases.
Read it in 10-K Mar 2, 2026 at sec.govopen_in_new